Cancer Gene Therapy Week
Susan Hasty, Publisher
Table of Contents . . . November 15th, 2004
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Cancer Gene Therapy Week | Other Publications
Drug Development - Epigenetic changes in hematopoietic malignancies offer novel treatment tactics
Oncology - Effects of tumor E-cadherin mutations on Wnt signaling determined
Oncology - Gene expression profiles yield clinicopathological staging of colorectal cancer
Oncology - New cancer target the focus of monoclonal antibody treatment
Apoptosis - AMID may be a p53-downstream gene involved in tumorigenesis
Bladder Cancer - N-acetyltransferase 1 involved in arylamine activation
Breast Cancer - Biotransformation enzyme gene variants linked to high breast cancer risk
Breast Cancer - Oncostatin M induces S100A9 gene expression in breast tumor cells
Breast Cancer - San Diego Susan Komen foundation affiliate presents 'Bras Down Broadway'
Business & Finance - Company provides Q3 update, reports on oncology, cardiovascular programs
Business and Finance - Pharmaceutical company restructures
Cancer Research - Biotech company initiates second phase 1 study of SNS-595 for cancer
Cancer Research - Photoactivation of Pba induces mitochondrial-mediated apoptosis in Jurkat cells
Cancer Therapy - Genomic effects of green tea EGCG elucidated
Cellular Therapy - Cell line manufacturer signs license for liver cells
Colon Cancer - Porphyrin, chlorin series better than Photofrin against colon cancer in vitro
Drug Development - Bioreactor company receives National Science Foundation grant
Drug Development - Pharma company completes humanization of 3G4 antibody
Finance - Biotech completes new financing
Genetics - Company announces new, speedy gene detection method
Glioma - N-cadherin expression inversely correlates with glioma tissue invasion
Malaria - Study shows Corixa's MPL adjuvant protected against uncomplicated malaria
Neurology - U.S. patent awarded for technology used in gene therapy trial
Oncology - New technology prevents breast cancer development in transgenic mice
Personnel - Biosciences company adds member to scientific advisory board
Personnel - Colin Scott, MD, joins glycobiology company
Prostate Cancer - Conditional deletion of Rb causes early stage prostate cancer
Prostate Cancer - Interference with SONIC HEDGEHOG-GLI1 signaling inhibits prostate cancer
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
